Creyos

Creyos

Share

Cambridge Brain Sciences is a leading web-based platform for the assessment of cognitive function, built for healthcare practitioners and researchers.

Find out more at cambridgebrainsciences.com. Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows researchers and healthcare providers to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires.

09/29/2026

๐Ÿง  โš•๏ธ Dementia begins as a breakdown in large-scale brain networks 5 to 10 years before obvious symptoms appear.

Health systems route those patients into neurology and geriatrics queues that stretch for months, which defers care during the window when intervention matters most.

One multi-state integrated delivery network redesigned that pathway and moved objective cognitive assessment into primary care.

Our white paper covers:
๐Ÿ‘‰ the science of the detection window
๐Ÿ‘‰ their selection criteria and rollout blueprint
๐Ÿ‘‰ and the financial case under both fee-for-service and value-based care.

The earlier you know, applied at system scale.

Get the white paper: https://hubs.li/Q04y2nwP0

09/28/2026

Awareness is an important part of changing the future of Alzheimerโ€™s and dementia, opening the door to earlier identification, more proactive care, and better support along the care journey.

๐Ÿง  Following World Alzheimerโ€™s Day, those conversations feel especially timely.

On October 6-7, Erin Smith, Chief Marketing Officer at Creyos, will be in Houston for the Alzheimer's Association Health Care Summit: Advancing Quality and Innovation.

Weโ€™re looking forward to conversations about what it takes to move brain health forward, from awareness to meaningful action in everyday care.

๐Ÿ“ Houston | October 6-7

If you're attending, be sure to say hello!

09/22/2026

๐Ÿง  An estimated 15.5 million U.S. adults had an ADHD diagnosis in 2023, according to the CDC. Roughly half were diagnosed as adults.

Each diagnosis initiates years of follow-up:
๐Ÿ‘‰ Is the medication working?
๐Ÿ‘‰ Should the dose change?
๐Ÿ‘‰ Is a shift in symptoms a treatment response, a bad week, or something else?

Most practices answer those questions with rating scales and self-report.

Our latest article looks at how Creyos supports monitoring ADHD over time with objective cognitive data, from baseline through follow-up: https://hubs.ly/Q04y2bQW0

09/21/2026

๐Ÿ’œ Today is World Alzheimer's Day, and this year's theme from Alzheimer's Disease International focuses on the value of an earlier diagnosis.

In the US, more than half of older adults diagnosed with dementia receive that diagnosis from a primary care physician. It often happens in a visit of about 18 minutes that also covers many other health concerns.

Our ebook, Confronting the Dementia Crisis, was written for primary care teams. It reviews current best practices for assessing MCI and dementia and includes a checklist for assessing practice readiness.

๐Ÿ‘‰ Download the free ebook here:
https://hubs.li/Q04x-VL10

09/18/2026

โš•๏ธ Primary care physicians deliver difficult news all the time. Cancer, heart failure, stroke risk, end-of-life care.

A dementia diagnosis is different. It touches memory, judgment, independence, family relationships, and a person's sense of self at once, which is why it cannot be treated as a single disclosure moment.

Dr. Anthony Zizza, a board-certified geriatrician and Chief Medical Officer at Element Care, writes about the conversation itself:
๐Ÿ‘‰ who should be in the room
๐Ÿ‘‰ how to be honest and still leave room for hope
๐Ÿ‘‰ and how the conversation changes with the stage of disease

Read it here: https://hubs.li/Q04xTBxl0

09/16/2026

This fall, weโ€™re looking forward to being part of important conversations about whatโ€™s next for dementia detection and care.

Across all three events, our focus is the same: how healthcare organizations can identify cognitive change earlier, create clearer pathways from screening to assessment, and better support patients throughout the dementia care journey.

This October, you can find us at:

๐Ÿ“ AMGA Integration Summit: October 5โ€“7 | Washington, DC
๐Ÿ“ Alzheimerโ€™s Association Health Care Summit: October 6โ€“7 | Houston, TX
๐Ÿ“ AAN Fall Conference: October 9โ€“11 | Las Vegas, NV

If youโ€™ll be attending, weโ€™d love to connect.

09/15/2026

๐Ÿ’Š Many older adults living with cognitive impairment take at least one anticholinergic medication, and higher burden independently predicts worse cognition.

Anticholinergics block acetylcholine signaling, the same pathway cholinesterase inhibitors work to increase. A medication list can end up internally contradictory, with one drug prescribed to support cognition and another working against it.

Screening for cognitive impairment in primary care can help surface these contributors, and reviewing the medication list is one of the things you can do once you know.

Dr. Anthony Zizza, a board-certified geriatrician and Chief Medical Officer at Element Care, walks through a practical deprescribing process.

Read it here: https://hubs.li/Q04xBPJ90

09/10/2026

๐Ÿง  55% of primary care physicians report that their communities have too few dementia care specialists.

When a cognitive screen comes back abnormal, that shortage means a referral often has a long waiting period, all while the patient is still taking the same medications and the family is still making daily decisions.

The earlier you know, the more you can do.

Dr. Anthony Zizza, a board-certified geriatrician and Chief Medical Officer at Element Care, lays out what primary care can do in the 30 days after an abnormal screen.

Read it here: https://hubs.li/Q04x9Qd80

09/08/2026

More than 90% of carers and members of the public say they would be encouraged to seek a dementia diagnosis if a disease-modifying treatment was available.

But a structured workup determines more than treatment eligibility. It can:
๐Ÿ‘‰ surface treatable contributors to cognitive change
๐Ÿ‘‰ initiate care planning while a patient can still take part
๐Ÿ‘‰ put adherence supports and medication review in place before a crisis

Knowing earlier opens up treatment, care, and support options all at once.

Our latest article looks at what earlier detection makes possible.

Read it here: https://hubs.li/Q04wYGsF0

09/02/2026

๐Ÿง  September is World Alzheimer's Month.

This year's theme, set by Alzheimer's Disease International, is:
The Earlier You Know, The More You Can Do: A Dementia Diagnosis Matters

We're spending the month on that idea, starting with the first half of it: Knowing earlier depends on whether screening can reach people.

In West Texas, the memory clinic at Texas Tech University Health Sciences Center serves more than 40 counties across 4 states.

Most of those communities had no cognitive screening programs in place locally, so people reached care only once a crisis had already arrived.

So the clinic went out to them, setting up in libraries, senior centers, and community halls. In about a year, they screened more than 600 people.

๐Ÿ‘‰ Read the full case study here: https://hubs.li/Q04wkhPr0

Want your business to be the top-listed Engineering Company in Toronto?
Click here to claim your Sponsored Listing.

Telephone

Address


214 King Street W. Suite 210
Toronto, ON
M5H3S6

Alerts

Be the first to know and let us send you an email when Creyos posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Subscribe

We will notify you when anything happens in Toronto.